Viral Vaccines

Production of viral vaccines

The Institute of Immunology, Inc. has a long-standing tradition in the manufacture of viral vaccines. Our own „know-how“ resulted in the development of the Edmonston-Zagreb vaccine strain which became available on the local market in 1968 as the authorised Measles Vaccine.

In the 1980-s, the Institute of Immunology qualified as a supplier of the Measles Vaccine for the UN. From then on, viral vaccines were distributed in different world markets proving to be safe and effective for millions of vaccinated children. According to WHO, active immunity which persists after vaccination with the Edmonston-Zagreb vaccine strain is better, according to WHO data, then after vaccination using other vaccine strains against measles (e.g. Schwarz).

The licence for production of the Measles Vaccine based on the Edmonston-Zagreb strain was sold to Switzerland, India and Mexico.

  • Swiss Serum and Vaccine Institute, Switzerland
  • Serum Institute of India, India
  • Gerencia General de Biologicos y Reactivos, Mexico

VIRAL VACCINES


02/23/2012
Institute of Immunology, Inc. in 2011 operated with a profit
more
02/14/2012
COLLABORATION BETWEEN INSTITUTE OF IMMUNOLOGY AND RUĐER BOŠKOVIĆ INSTITUTE
more
01/16/2012
MARIJA BRGLES
more
10/19/2011
TIHANA KURTOVIĆ
more
09/30/2011
Leaders of TRANSVAC have accepted the application of dr. Jelena Ivančić Jelečki and colleagues from Molecular Biomedicine Unit
more
09/28/2011
Human Rabies Prevention - 28 SEPTEMBER - The World Rabies Day
more
08/25/2011
Our scientists and experts at the conference Biologics & Biotechnology: Advancing Quality Standards through Analytics & Assays
more
08/24/2011
Dr. Tanja Košutić Gulija and colleagues from Molecular Biomedicine Unit have published an article in Electrophoresis Journal
more
06/16/2011
The work of Dr.sc. Marija Brgles has been published in Journal of Chromatography A
more
05/19/2011
Researches from the Institute of Immunology have developed a new method for concentration of rubella virus
more